IP Library Granted Patent US 8,945,179
Granted Patent B2
US 8,945,179 · App. 13/795,838 · Granted Feb 3, 2015

Single disc occlusionary patent foramen ovale closure device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,179
App. No.
13/795,838
Granted
Feb 3, 2015
Kind
B2
Abstract

Described are method and device for closing a passageway in a body, for example a patent foramen ovale (PFO) in a heart, and related methods of using such closure devices for closing the passageway. The method includes locating a distal end of a closure device adjacent to the passageway. The closure device may include a closure line with proximal and distal ends, an expandable tissue anchor located along the distal end of the closure line, and an expandable occluder member located along the proximal end of the closure line. The expandable tissue anchor is deployed into tissue adjacent to the passageway. The expandable occluder member is deployed adjacent to the passageway such that the expandable occluder member substantially covers the second opening to the passageway.

Claims (6)

1. A method of closing a persistent passageway in a heart between a septum primum and septum secundum, the passageway having a first and a second open end, comprising:

locating a distal end of a closure device adjacent to the persistent passageway, the closure device having a closure line with proximal and distal ends, an expandable tissue anchor located along the distal end of the closure line, and an expandable occluder member located along the proximal end of the closure line;

deploying the expandable tissue anchor into a septal tissue of only one of the septum primum and septum secundum adjacent to the persistent passageway;

deploying the expandable occluder member adjacent to the persistent passageway by piercing a surface of the tissue with the expandable tissue anchor and expanding the tissue anchor within the septal tissue without the anchor detaching from the septal tissue such that the expandable occluder member substantially covers the second opening to the persistent passageway.

2. The method of claim 1 wherein deploying the expandable occluder member adjacent to the passageway comprises expanding the occluder member from a first configuration to a second configuration, and tensioning the occluder against the tissue to substantially cover the persistent passageway.

3. The method of claim 2 wherein tensioning the occluder against the tissue comprises unilaterally displacing the occluder distally along the closure line.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2025
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ACCESS CLOSURE, INC.; CORDIS US CORP.
Reel/Frame 073060/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →
SECURITY INTEREST Recorded Aug 24, 2021
From: ACCESS CLOSURE, INC.; CORDIS US CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 057292/0001 →